1QGEN logo

Qiagen BIT:1QGEN Stock Report

Last Price

€40.05

Market Cap

€8.8b

7D

3.1%

1Y

-6.8%

Updated

03 May, 2024

Data

Company Financials +

1QGEN Stock Overview

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide.

1QGEN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 1QGEN from our risk checks.

Qiagen N.V. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Qiagen
Historical stock prices
Current Share PriceUS$40.05
52 Week HighUS$42.11
52 Week LowUS$37.25
Beta0.42
1 Month Change3.58%
3 Month Change0.33%
1 Year Change-6.84%
3 Year Change-2.34%
5 Year Changen/a
Change since IPO1.33%

Recent News & Updates

Recent updates

Shareholder Returns

1QGENIT Life SciencesIT Market
7D3.1%-0.7%-1.7%
1Y-6.8%-14.6%17.4%

Return vs Industry: 1QGEN exceeded the Italian Life Sciences industry which returned -15% over the past year.

Return vs Market: 1QGEN underperformed the Italian Market which returned 20.4% over the past year.

Price Volatility

Is 1QGEN's price volatile compared to industry and market?
1QGEN volatility
1QGEN Average Weekly Movement2.8%
Life Sciences Industry Average Movement6.1%
Market Average Movement4.4%
10% most volatile stocks in IT Market7.7%
10% least volatile stocks in IT Market2.8%

Stable Share Price: 1QGEN has not had significant price volatility in the past 3 months.

Volatility Over Time: 1QGEN's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19845,900Thierry Bernardwww.qiagen.com

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing.

Qiagen N.V. Fundamentals Summary

How do Qiagen's earnings and revenue compare to its market cap?
1QGEN fundamental statistics
Market cap€8.80b
Earnings (TTM)€312.98m
Revenue (TTM)€1.80b

28.3x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1QGEN income statement (TTM)
RevenueUS$1.94b
Cost of RevenueUS$657.25m
Gross ProfitUS$1.28b
Other ExpensesUS$944.52m
EarningsUS$336.94m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.52
Gross Margin66.10%
Net Profit Margin17.38%
Debt/Equity Ratio43.3%

How did 1QGEN perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.